Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$23.14 - $49.68 $156,935 - $336,929
-6,782 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $372,331 - $713,534
6,782 New
6,782 $426,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.95B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Investment Management Corp Of Ontario Portfolio

Follow Investment Management Corp Of Ontario and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Corp Of Ontario, based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Corp Of Ontario with notifications on news.